InsiderClue
Stocks · Health care · Pharmaceutical Preparations

LIGAND PHARMACEUTICALS INC

LGND Clue Score50
United States Fiscal year ends December CIK 0000886163 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

47
Insider
Date
Role
Action
Shares
Price
Amount
Jason Aryeh
2 Nov 2026
Director
Sell
700
$320.43
$224.30K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$320.49
$16.02K
Jason Aryeh
30 Oct 2026
Director
Sell
1,209
$320.42
$387.38K
Jason Aryeh
30 Oct 2026
Director
Sell
52
$320.24
$16.65K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$318.23
$15.91K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$317.74
$15.89K
Martine Zimmermann
10 Sep 2026
Director
Sell
1,200
$285.00
$342.00K
Jason Aryeh
11 Jun 2026
Director
Sell
4,500
$250.00
$1.13M
John L Lamattina
10 Jun 2026
Director
Sell
3,405
$251.62
$856.75K
John L Lamattina
10 Jun 2026
Director
Sell
697
$249.53
$173.92K
John L Lamattina
10 Jun 2026
Director
Sell
232
$248.11
$57.56K
John L Lamattina
10 Jun 2026
Director
Sell
257
$247.22
$63.54K
Jason Aryeh
10 Jun 2026
Director
Sell
500
$250.00
$125.00K
Stephen L Sabba
23 Mar 2026
Director
Sell
1,000
$207.87
$207.87K
Octavio Espinoza
12 Dec 2025
Chief Financial Officer
Sell
1,804
$188.31
$339.71K
Jason Aryeh
23 Sep 2025
Director
Sell
954
$171.92
$164.02K
Jason Aryeh
23 Sep 2025
Director
Sell
4,628
$170.96
$791.22K
Jason Aryeh
23 Sep 2025
Director
Sell
4,418
$170.41
$752.85K
Andrew Reardon
23 Jun 2025
CLO & Secretary
Sell
500
$114.08
$57.04K
Andrew Reardon
10 Jun 2025
CLO & Secretary
Sell
500
$114.54
$57.27K
Andrew Reardon
15 May 2025
CLO & Secretary
Sell
1,000
$104.00
$104.00K
Octavio Espinoza
4 Mar 2025
Chief Financial Officer
Sell
5,000
$115.03
$575.15K
Octavio Espinoza
23 Dec 2024
Chief Financial Officer
Sell
2,104
$116.37
$244.85K
Octavio Espinoza
20 Sep 2024
Chief Financial Officer
Sell
800
$103.95
$83.16K
Octavio Espinoza
20 Sep 2024
Chief Financial Officer
Sell
275
$103.86
$28.56K
Octavio Espinoza
20 Sep 2024
Chief Financial Officer
Sell
200
$103.98
$20.80K
Matthew E Korenberg
26 Aug 2024
President & COO
Sell
5,212
$106.32
$554.15K
Matthew E Korenberg
26 Aug 2024
President & COO
Sell
6,177
$105.02
$648.68K
Matthew E Korenberg
23 Aug 2024
President & COO
Sell
4,275
$105.13
$449.44K
Matthew E Korenberg
23 Aug 2024
President & COO
Sell
2,037
$104.09
$212.04K
Matthew E Korenberg
22 Aug 2024
President & COO
Sell
1,157
$105.54
$122.11K
Matthew E Korenberg
9 Aug 2024
President & COO
Sell
18,245
$98.50
$1.80M
Octavio Espinoza
16 May 2024
Chief Financial Officer
Sell
2,264
$86.00
$194.71K
Octavio Espinoza
15 May 2024
Chief Financial Officer
Sell
5,873
$86.01
$505.15K
Matthew E Korenberg
14 May 2024
President & Chief Operating
Sell
520
$85.68
$44.56K
Matthew E Korenberg
14 May 2024
President & Chief Operating
Sell
13,638
$85.08
$1.16M
Matthew E Korenberg
13 May 2024
President & Chief Operating
Sell
3,440
$84.54
$290.83K
Nancy Ryan Gray
9 May 2024
Director
Sell
934
$83.20
$77.71K
John W Kozarich
16 May 2023
Director
Sell
4,444
$77.20
$343.08K
Andrew Reardon
24 Mar 2023
See Remarks
Sell
300
$69.92
$20.98K
John L Higgins
16 Dec 2022
Director
Sell
10,000
$61.87
$618.66K
John L Higgins
17 Nov 2022
Chief Executive Officer
Sell
10,000
$78.32
$783.17K
Octavio Espinoza
9 Nov 2022
Chief Financial Officer
Sell
1,696
$75.64
$128.28K
John L Higgins
16 Sep 2022
Chief Executive Officer
Sell
3,000
$89.35
$268.05K
John L Higgins
15 Sep 2022
Chief Executive Officer
Sell
2,000
$90.00
$180.00K
John L Higgins
12 Nov 2021
Chief Executive Officer
Sell
3,000
$160.50
$481.50K
Todd C Davis
10 Feb 2021
Director
Sell
5,083
$213.14
$1.08M
Showing 250 of 377 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 418
Amendments (4/A) skipped 11
Filings about a different issuer 6
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 149
Sales at will 85
Transactions with no price 0
Shares from compensation/vesting 2,217,470
Sales filed before the plan box existed 45
History held since 29 Sep 2006